Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Besonprodil

Next Previous
Drug Profile

Besonprodil

Alternative Names: CI 1041; CO 200461; PD 196860

Latest Information Update: 06 Aug 2009

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Analgesics; Antiepileptic drugs; Antiparkinsonians; Neuroprotectants; Small molecules
  • Mechanism of Action NR2B N-Methyl-D-Aspartate antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Neuropathic pain; Pain; Parkinson's disease

Most Recent Events

  • 21 Nov 2002 No development reported - Phase-I for Neuropathic pain in USA (unspecified route)
  • 21 Nov 2002 No development reported - Phase-I for Pain in USA (unspecified route)
  • 28 Nov 2001 A preclinical study has been added to the adverse events and Parkinson's Disease pharmacodynamics section

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top